{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:32:57Z","timestamp":1790019177739,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.leukres.2005.11.014","type":"journal-article","created":{"date-parts":[[2006,1,7]],"date-time":"2006-01-07T12:21:42Z","timestamp":1136636502000},"page":"1201-1205","source":"Crossref","is-referenced-by-count":33,"title":["Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): Detection of FIP1L1\/PDGFR\u03b1, classification by WHO criteria, and response to therapy with imatinib"],"prefix":"10.1016","volume":"30","author":[{"given":"Stefan","family":"Florian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Esterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar A.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sillaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2005.11.014_bib1","first-page":"2","article-title":"Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome","volume":"95","author":"Bain","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-4608(98)00099-5","article-title":"Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with a unique chromosomal abnormality","volume":"107","author":"Oliver","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2005.11.014_bib3","first-page":"29","article-title":"Chronic eosinophilic leukemia and hypereosinophilic syndrome","volume":"vol. 1","author":"Bain","year":"2001"},{"key":"10.1016\/j.leukres.2005.11.014_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000085559","article-title":"Molecular classification and pathogenesis of eosinophilic disorders: 2005 update","volume":"114","author":"Gotlib","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000085562","article-title":"Modern diagnosis and treatment of primary eosinophilia","volume":"114","author":"Tefferi","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib6","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib7","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2003-01-0081","article-title":"Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome","volume":"101","author":"Cortes","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib8","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","article-title":"Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002770050434","article-title":"Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases","volume":"77","author":"Ceretelli","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000085560","article-title":"Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis","volume":"114","author":"Butterfield","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib11","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2003-06-1824","article-title":"The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management","volume":"103","author":"Gotlib","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib12","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib13","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1073\/pnas.0932698100","article-title":"Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome","volume":"100","author":"Griffin","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2005.11.014_bib14","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib15","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1182\/blood-2004-07-2680","article-title":"Eosinophilic leukemia and idiopathic hypereosinophilic syndrome are mutually exclusive diagnoses","volume":"104","author":"Bain","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib16","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.leukres.2005.11.014_bib17","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis","volume":"108","author":"Valent","year":"1996","journal-title":"Wien Klin Wschr"},{"key":"10.1016\/j.leukres.2005.11.014_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2005.11.014_bib19","first-page":"291","article-title":"Mastocytosis","volume":"vol. 1","author":"Valent","year":"2001"},{"key":"10.1016\/j.leukres.2005.11.014_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.leukres.2005.11.014_bib21","first-page":"197","article-title":"Systemic mastocytosis: current concepts and treatment advances","volume":"3","author":"Tefferi","year":"2004","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.leukres.2005.11.014_bib22","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2005.11.014_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2005.11.014_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","article-title":"Mutation analysis of c-kit in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis","volume":"113","author":"Fritsche-Polanz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"Akin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2005.11.014_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","article-title":"Significance of systemic mast cell disease with associated hematologic disorders","volume":"62","author":"Travis","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2005.11.014_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2141.1990.tb07870.x","article-title":"Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders","volume":"76","author":"Horny","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0002-9343(91)90214-I","article-title":"Hematologic manifestation of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis","volume":"91","author":"Lawrence","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.leukres.2005.11.014_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000048186","article-title":"Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis","volume":"127","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.leukres.2005.11.014_bib31","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V94.5.1820","article-title":"Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13)","volume":"94","author":"Cools","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.11.014_bib32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.0007-1048.2002.03340.x","article-title":"A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias","volume":"116","author":"K\u00f6nig","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2005.11.014_bib33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2005.11.014_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.1977.tb01003.x","article-title":"Radioimmunoassay of human eosinophil cationic protein","volume":"37","author":"Venge","year":"1977","journal-title":"Br J Haematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605004327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605004327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:34:46Z","timestamp":1586651686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212605004327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0145212605004327"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2005.11.014","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}